B
Brijeshwar Maini
Researcher at Florida Atlantic University
Publications - 60
Citations - 4753
Brijeshwar Maini is an academic researcher from Florida Atlantic University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 44 publications receiving 3620 citations. Previous affiliations of Brijeshwar Maini include Pinnacle Financial Partners & Harrisburg Hospital.
Papers
More filters
Journal ArticleDOI
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
Michael J. Reardon,N. M. Van Mieghem,Jeffrey J. Popma,Neal S. Kleiman,Lars Søndergaard,Mubashir Mumtaz,David H. Adams,G. M. Deeb,Brijeshwar Maini,Hemal Gada,Stanley Chetcuti,Thomas G. Gleason,John Heiser,Ruediger Lange,William Merhi,Jae Oh,Peter Skov Olsen,Nicolo Piazza,M. Williams,Stephan Windecker,Steven J. Yakubov,Eberhard Grube,Raj Makkar,Jonathan S. Lee,John V. Conte,E. Vang,Hang Nguyen,Yanping Chang,Andrew S. Mugglin,Patrick W. Serruys,Arie-Pieter Kappetein +30 more
TL;DR: TAVR was a noninferior alternative to surgery in patients with severe aortic stenosis at intermediate surgical risk, with a different pattern of adverse events associated with each procedure.
Journal ArticleDOI
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
William W. O'Neill,Neal S. Kleiman,Jeffrey W. Moses,José P.S. Henriques,Simon R. Dixon,Joseph M. Massaro,Igor F. Palacios,Brijeshwar Maini,Suresh Mulukutla,Vladimír Džavík,Jeffrey J. Popma,Pamela S. Douglas,Magnus Ohman +12 more
TL;DR: In this paper, the authors compared intra-aortic balloon pump (IABP) and Impella 2.5 for percutaneous coronary intervention in patients with complex multivessel, or left main disease.
Journal ArticleDOI
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
William W. O'Neill,Theodore Schreiber,David Wohns,Charanjit S. Rihal,Srihari S. Naidu,Andrew B. Civitello,Simon R. Dixon,Joseph M. Massaro,Brijeshwar Maini,E. Magnus Ohman +9 more
TL;DR: The results of this study suggest that early initiation of hemodynamic support prior to PCI with Impella 2.5 is associated with more complete revascularization and improved survival in the setting of refractory CS complicating an acute myocardial infarction.
Journal ArticleDOI
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement
G. Michael Deeb,Michael J. Reardon,Stan Chetcuti,Himanshu J. Patel,P. Michael Grossman,Steven J. Yakubov,Neal S. Kleiman,Joseph S. Coselli,Thomas G. Gleason,Joon S. Lee,James B. Hermiller,John Heiser,William Merhi,George L. Zorn,Peter Tadros,Newell Robinson,George Petrossian,G. Chad Hughes,J. Kevin Harrison,Brijeshwar Maini,Mubashir Mumtaz,John V. Conte,Jon R. Resar,Vicken Aharonian,Thomas A. Pfeffer,Jae K. Oh,Hongyan Qiao,David H. Adams,Jeffrey J. Popma,CoreValve U.S. Pivotal High Risk Trial Clinical Investigators +29 more
TL;DR: Patients with severe aortic stenosis at increased risk for surgery had improved 3-year clinical outcomes after TAVR compared with surgery, and aorti valve hemodynamics were more favorable in TAVr patients without differences in structural valve deterioration.
Journal ArticleDOI
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock
Mir B Basir,Theodore Schreiber,Cindy L. Grines,Simon R. Dixon,Jeffrey W. Moses,Brijeshwar Maini,Akshay Khandelwal,E. Magnus Ohman,William W. O'Neill +8 more
TL;DR: MCS implantation early after shock onset, before initiation of inotropes or vasopressors and before PCI, is independently associated with improved survival in patients presenting with AMICS.